CA Stock MarketDetailed Quotes

TRIL Trillium Therapeutics Inc

Watchlist
  • 23.330
  • 0.0000.00%
15min DelayTrading Apr 11 09:30 ET
2.45BMarket Cap-36058P/E (TTM)

Trillium Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
(Q2)Jun 30, 2020
(Q1)Mar 31, 2020
(FY)Dec 31, 2019
(Q4)Dec 31, 2019
Total revenue
0
-91.30%10K
0
19.35%148K
33K
0
360.00%115K
0
124K
0
Operating revenue
--0
-91.30%10K
--0
19.35%148K
--33K
--0
360.00%115K
--0
--124K
--0
Cost of revenue
Gross profit
Operating expense
49.69%19.45M
-21.76%18.68M
-32.10%11.31M
90.06%61.6M
-0.90%8.08M
77.05%12.99M
174.19%23.87M
102.74%16.66M
-10.89%32.41M
-2.53%8.15M
Selling and administrative expenses
72.64%9.53M
-71.99%4.68M
-53.83%5.39M
533.39%36.26M
-26.98%2.37M
428.54%5.52M
1,961.36%16.7M
1,750.24%11.68M
105.46%5.72M
1,772.07%3.24M
-General and administrative expense
72.64%9.53M
-71.99%4.68M
-53.83%5.39M
533.39%36.26M
-26.98%2.37M
428.54%5.52M
1,961.36%16.7M
1,750.24%11.68M
105.46%5.72M
1,772.07%3.24M
Research and development costs
32.76%9.93M
95.14%14M
18.77%5.92M
-5.02%25.35M
16.32%5.71M
18.76%7.48M
-9.14%7.17M
-34.26%4.99M
-20.54%26.69M
-40.04%4.91M
Operating profit
-49.69%-19.45M
21.43%-18.67M
32.10%-11.31M
-90.33%-61.46M
1.30%-8.04M
-79.48%-12.99M
-173.66%-23.76M
-102.74%-16.66M
11.23%-32.29M
2.53%-8.15M
Net non-operating interest income (expenses)
-62.11%183K
-20.18%352K
28.40%529K
236.52%2.01M
192.61%673K
323.68%483K
264.46%441K
212.12%412K
-25.75%597K
15.28%230K
Non-operating interest income
-62.11%183K
-20.18%352K
28.40%529K
236.52%2.01M
601.04%673K
200.00%483K
159.41%441K
142.35%412K
-28.84%597K
-54.06%96K
Other net income (expenses)
-15.38%11K
-89.60%13K
-45.83%-35K
103.17%202K
101.14%88K
100.54%13K
-96.64%125K
-140.00%-24K
-334.97%-6.36M
-596.28%-7.74M
Gain on sale of security
-15.38%11K
-89.60%13K
-45.83%-35K
103.17%202K
100.82%88K
-97.63%13K
-96.64%125K
-140.00%-24K
-334.97%-6.36M
-785.58%-10.69M
Income before tax
-54.08%-19.26M
21.08%-18.3M
33.52%-10.82M
-55.68%-59.24M
53.50%-7.28M
-31.14%-12.5M
-379.13%-23.19M
-102.75%-16.28M
-15.81%-38.05M
-137.20%-15.66M
Income tax
555.56%59K
250.00%98K
82.61%42K
264.29%102K
950.00%42K
-30.77%9K
211.11%28K
1,050.00%23K
300.00%28K
152.83%4K
Earnings from equity interest net of tax
Net income
-54.44%-19.32M
20.76%-18.4M
33.35%-10.86M
-55.84%-59.35M
53.24%-7.32M
-31.06%-12.51M
-378.82%-23.22M
-102.99%-16.3M
-15.87%-38.08M
-137.21%-15.66M
Net income continuous operations
-54.44%-19.32M
20.76%-18.4M
33.35%-10.86M
-55.84%-59.35M
53.24%-7.32M
-31.06%-12.51M
-378.82%-23.22M
-102.99%-16.3M
-15.87%-38.08M
-137.21%-15.66M
Noncontrolling interests
Net income attributable to the company
-54.44%-19.32M
20.76%-18.4M
33.35%-10.86M
-55.84%-59.35M
53.24%-7.32M
-31.06%-12.51M
-378.82%-23.22M
-102.99%-16.3M
-15.87%-38.08M
-137.21%-15.66M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-54.44%-19.32M
20.76%-18.4M
33.35%-10.86M
-55.84%-59.35M
53.24%-7.32M
-31.06%-12.51M
-378.82%-23.22M
-102.99%-16.3M
-15.87%-38.08M
-137.21%-15.66M
Diluted earnings per share
-28.57%-0.18
35.71%-0.18
56.00%-0.11
39.13%-0.7
81.82%-0.04
58.82%-0.14
-55.56%-0.28
45.65%-0.25
51.06%-1.15
47.96%-0.22
Basic earnings per share
-28.57%-0.18
35.71%-0.18
56.00%-0.11
39.13%-0.7
81.82%-0.04
58.82%-0.14
-55.56%-0.28
45.65%-0.25
51.06%-1.15
47.96%-0.22
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020(Q2)Jun 30, 2020(Q1)Mar 31, 2020(FY)Dec 31, 2019(Q4)Dec 31, 2019
Total revenue 0-91.30%10K019.35%148K33K0360.00%115K0124K0
Operating revenue --0-91.30%10K--019.35%148K--33K--0360.00%115K--0--124K--0
Cost of revenue
Gross profit
Operating expense 49.69%19.45M-21.76%18.68M-32.10%11.31M90.06%61.6M-0.90%8.08M77.05%12.99M174.19%23.87M102.74%16.66M-10.89%32.41M-2.53%8.15M
Selling and administrative expenses 72.64%9.53M-71.99%4.68M-53.83%5.39M533.39%36.26M-26.98%2.37M428.54%5.52M1,961.36%16.7M1,750.24%11.68M105.46%5.72M1,772.07%3.24M
-General and administrative expense 72.64%9.53M-71.99%4.68M-53.83%5.39M533.39%36.26M-26.98%2.37M428.54%5.52M1,961.36%16.7M1,750.24%11.68M105.46%5.72M1,772.07%3.24M
Research and development costs 32.76%9.93M95.14%14M18.77%5.92M-5.02%25.35M16.32%5.71M18.76%7.48M-9.14%7.17M-34.26%4.99M-20.54%26.69M-40.04%4.91M
Operating profit -49.69%-19.45M21.43%-18.67M32.10%-11.31M-90.33%-61.46M1.30%-8.04M-79.48%-12.99M-173.66%-23.76M-102.74%-16.66M11.23%-32.29M2.53%-8.15M
Net non-operating interest income (expenses) -62.11%183K-20.18%352K28.40%529K236.52%2.01M192.61%673K323.68%483K264.46%441K212.12%412K-25.75%597K15.28%230K
Non-operating interest income -62.11%183K-20.18%352K28.40%529K236.52%2.01M601.04%673K200.00%483K159.41%441K142.35%412K-28.84%597K-54.06%96K
Other net income (expenses) -15.38%11K-89.60%13K-45.83%-35K103.17%202K101.14%88K100.54%13K-96.64%125K-140.00%-24K-334.97%-6.36M-596.28%-7.74M
Gain on sale of security -15.38%11K-89.60%13K-45.83%-35K103.17%202K100.82%88K-97.63%13K-96.64%125K-140.00%-24K-334.97%-6.36M-785.58%-10.69M
Income before tax -54.08%-19.26M21.08%-18.3M33.52%-10.82M-55.68%-59.24M53.50%-7.28M-31.14%-12.5M-379.13%-23.19M-102.75%-16.28M-15.81%-38.05M-137.20%-15.66M
Income tax 555.56%59K250.00%98K82.61%42K264.29%102K950.00%42K-30.77%9K211.11%28K1,050.00%23K300.00%28K152.83%4K
Earnings from equity interest net of tax
Net income -54.44%-19.32M20.76%-18.4M33.35%-10.86M-55.84%-59.35M53.24%-7.32M-31.06%-12.51M-378.82%-23.22M-102.99%-16.3M-15.87%-38.08M-137.21%-15.66M
Net income continuous operations -54.44%-19.32M20.76%-18.4M33.35%-10.86M-55.84%-59.35M53.24%-7.32M-31.06%-12.51M-378.82%-23.22M-102.99%-16.3M-15.87%-38.08M-137.21%-15.66M
Noncontrolling interests
Net income attributable to the company -54.44%-19.32M20.76%-18.4M33.35%-10.86M-55.84%-59.35M53.24%-7.32M-31.06%-12.51M-378.82%-23.22M-102.99%-16.3M-15.87%-38.08M-137.21%-15.66M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -54.44%-19.32M20.76%-18.4M33.35%-10.86M-55.84%-59.35M53.24%-7.32M-31.06%-12.51M-378.82%-23.22M-102.99%-16.3M-15.87%-38.08M-137.21%-15.66M
Diluted earnings per share -28.57%-0.1835.71%-0.1856.00%-0.1139.13%-0.781.82%-0.0458.82%-0.14-55.56%-0.2845.65%-0.2551.06%-1.1547.96%-0.22
Basic earnings per share -28.57%-0.1835.71%-0.1856.00%-0.1139.13%-0.781.82%-0.0458.82%-0.14-55.56%-0.2845.65%-0.2551.06%-1.1547.96%-0.22
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg